Cited by 171Prenatal Screening and DiagnosticsDown syndrome and intellectual disability researchFetal and Pediatric Neurological Disorders

Relation between increased fetal nuchal translucency thickness and chromosomal defects

Kagan, Karl Oliver, Avgidou, Kyriaki, Molina, Francisca S., Gajewska, Katarzyna, Nicolaides, Kypros H.·2006·Obstetrics & Gynecology

Abstract

OBJECTIVE: To examine the prevalence and distribution of all chromosomal defects in fetuses with increased nuchal translucency thickness. METHODS: Assessment of risk for trisomy 21 was carried out by a combination of maternal age and fetal nuchal translucency thickness at 11-13 + 6 weeks. A search of the database was made to identify, first, all singleton pregnancies in which fetal karyotyping was carried out and, second, the cases where the fetal nuchal translucency was equal to or above the 95th centile for fetal crown-rump length. The prevalence and distribution of chromosomal defects were determined for each nuchal translucency category: between the 95th centile for crown-rump length and 3.4 mm, 3.5-4.4 mm, 4.5-5.4 mm, 5.5-6.4 mm, 6.5-7.4 mm, 7.5-8.4 mm, 8.5-9.4 mm, 9.5-10.4 mm, 10.5-11.4 mm, and 11.5 mm or more. RESULTS: The search identified 11,315 pregnancies. The median maternal age was 34.5 (range 15-50) years, and the median fetal crown-rump length was 64 (range 45-84) mm. The fetal karyotype was abnormal in 2,168 (19.2%) pregnancies, and the incidence of chromosomal defects increased with nuchal translucency thickness from approximately 7% for those with nuchal translucency between the 95th centile for crown-rump length and 3.4 mm to 75% for nuchal translucency of 8.5 mm or more. In the majority of fetuses with trisomy 21, the nuchal translucency thickness was less then 4.5 mm, whereas in the majority of fetuses with trisomies 13 or 18 it was 4.5-8.4 mm, and in those with Turner syndrome it was 8.5 mm or more. CONCLUSION: In fetuses with increased nuchal translucency, approximately one half of the chromosomally abnormal group is affected by defects other than trisomy 21. The distribution of nuchal translucency is different for each type of chromosomal defect. LEVEL OF EVIDENCE: II-3.

Integrity signals

Registry

Crossref · 10.1097/01.aog.0000191301.63871.c6

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kagan, K. O., Avgidou, K., Molina, F. S., Gajewska, K., & Nicolaides, K. H.
Affiliations
King's College London (GB)
Venue
Obstetrics & Gynecology
Published
2006-01
Volume
107
Issue
1
Pages
6-10
ISSN
0029-7844 (ISSN-L)
OpenAlex
W2087137823
Cited by
171
References
23
Citations by year
2026: 5 · 2025: 8 · 2024: 7 · 2023: 8 · 2022: 17 · 2021: 8 · 2020: 6 · 2019: 12 · 2018: 8 · 2017: 7 · 2016: 10 · 2015: 14 · 2014: 8 · 2013: 11 · 2012: 7
FWCI
7.78
Type
journal article
Language
en
Open access
closed
Locations
  • Obstetrics and Gynecology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Fetal and Pediatric Neurological Disorders
Keywords
nuchal translucency, chromosomal abnormalities, Down syndrome, trisomy 13, trisomy 18, Turner syndrome, prenatal diagnosis, fetal karyotyping, maternal age, crown-rump length, first-trimester screening, fetal growth restriction, fetal malformations, fetal biophysical profile
MeSH terms
Adolescent, Adult, Chromosome Aberrations, Down Syndrome, Female, Genetic Counseling, Humans, Karyotyping, Maternal Age, Middle Aged, Pedigree, Pregnancy, Pregnancy Trimester, First, Probability, Retrospective Studies, Trisomy, Prevalence, Ultrasonography, Prenatal, Risk Assessment, Genetic Predisposition to Disease, Nuchal Translucency Measurement

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review